Cargando…
Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management
IMPORTANCE: Randomized clinical trials (RCTs) are an essential method of evaluating health care interventions and a cornerstone for evidence-based health care. However, RCTs have become increasingly complex and costly, which is particularly challenging for independent investigator-initiated clinical...
Autores principales: | McLennan, Stuart, Griessbach, Alexandra, Briel, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173375/ https://www.ncbi.nlm.nih.gov/pubmed/34076698 http://dx.doi.org/10.1001/jamanetworkopen.2021.11847 |
Ejemplares similares
-
Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical Trials
por: McLennan, Stuart, et al.
Publicado: (2021) -
Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study
por: Taji Heravi, Ala, et al.
Publicado: (2022) -
Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
por: Briel, Matthias, et al.
Publicado: (2021) -
Practices and Attitudes of Bavarian Stakeholders Regarding the Secondary Use of Health Data for Research Purposes During the COVID-19 Pandemic: Qualitative Interview Study
por: McLennan, Stuart, et al.
Publicado: (2022) -
Scoping review and characteristics of publicly available checklists for assessing clinical trial feasibility
por: Gloy, Viktoria, et al.
Publicado: (2022)